Xingtai People's Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT02846207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Xingtai People's Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

octreotide (sandostatin) (1 trial)

terlipressin (Terlivaz) (1 trial)

Drugs in Other Trials (4)

huoxue (1 trial)

propranolol (inderal) (1 trial)

yiqi (1 trial)

yiqi huoxue (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hemorrhage (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6